Literature DB >> 15106822

Cognitive impairment in mice over-expressing gamma-aminobutyric acid transporter 1 (GAT1).

Jia-Hua Hu1, Ying-Hua Ma, Jie Jiang, Na Yang, Shu-hui Duan, Zhi-Hua Jiang, Zhen-Tong Mei, Jian Fei, Li-He Guo.   

Abstract

There is increasing evidence that GABAergic system plays an important role in the neural control of learning and memory processes. GAT1 over-expressing mice (NA) were generated, in which GAT1 is under the control of a neuron-specific enolase (NSE) promoter, to investigate effects of GABA transporter on cognitive function. Our results revealed that NA mice displayed cognitive deterioration in associative learning ability and new object recognition retention, compared with the wild-type littermates (WT2). However, the impaired cognitive function of transgenic mice could be rescued after chronic administration of GAT1 selective inhibitor for 6 days. In addition, there was no change of the expression of NMDA receptors in NA mice. Taken together, we show a potentially important role for GAT1 in the neural control of cognitive processes, and indicate great potential for GAT1 as a clinical target of cognitive disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106822     DOI: 10.1097/00001756-200401190-00003

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  10 in total

Review 1.  Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.

Authors:  L Lyon; L M Saksida; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2011-11-10       Impact factor: 4.530

2.  γ-aminobutyric acid transporter-1 is involved in anxiety-like behaviors and cognitive function in knockout mice.

Authors:  Xue Gong; Yiye Shao; Bing Li; Long Chen; Cuicui Wang; Yinghui Chen
Journal:  Exp Ther Med       Date:  2015-06-15       Impact factor: 2.447

3.  Associations between catecholaminergic, GABAergic, and serotonergic genes and self-reported attentional function in oncology patients and their family caregivers.

Authors:  John D Merriman; Bradley E Aouizerat; Janine K Cataldo; Laura B Dunn; Kord Kober; Dale J Langford; Claudia West; Bruce A Cooper; Steven M Paul; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2014-12-15       Impact factor: 2.398

4.  Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice.

Authors:  Yaisa Andrews-Zwilling; Nga Bien-Ly; Qin Xu; Gang Li; Aubrey Bernardo; Seo Yeon Yoon; Daniel Zwilling; Tonya Xue Yan; Ligong Chen; Yadong Huang
Journal:  J Neurosci       Date:  2010-10-13       Impact factor: 6.167

Review 5.  Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids.

Authors:  Emma Puighermanal; Arnau Busquets-Garcia; Rafael Maldonado; Andrés Ozaita
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 6.  Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease.

Authors:  Ramsey Najm; Emily A Jones; Yadong Huang
Journal:  Mol Neurodegener       Date:  2019-06-11       Impact factor: 14.195

7.  Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice.

Authors:  Laura Leung; Yaisa Andrews-Zwilling; Seo Yeon Yoon; Sachi Jain; Karen Ring; Jessica Dai; Max Mu Wang; Leslie Tong; David Walker; Yadong Huang
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

8.  Hilar GABAergic interneuron activity controls spatial learning and memory retrieval.

Authors:  Yaisa Andrews-Zwilling; Anna K Gillespie; Alexxai V Kravitz; Alexandra B Nelson; Nino Devidze; Iris Lo; Seo Yeon Yoon; Nga Bien-Ly; Karen Ring; Daniel Zwilling; Gregory B Potter; John L R Rubenstein; Anatol C Kreitzer; Yadong Huang
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

Review 9.  Neurobiology of memory and anxiety: from genes to behavior.

Authors:  Allan V Kalueff
Journal:  Neural Plast       Date:  2007-01-10       Impact factor: 3.599

Review 10.  Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives.

Authors:  Leslie M Tong; Helen Fong; Yadong Huang
Journal:  Exp Mol Med       Date:  2015-03-13       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.